170 related articles for article (PubMed ID: 15141520)
1. [Comparison of the cost of treatment of premature labor with atosiban or beta-sympathomimetics from the perspective of the health care payer--a pharmacoeconomic model].
Hrubý K
Ceska Gynekol; 2004 Mar; 69(2):96-105. PubMed ID: 15141520
[TBL] [Abstract][Full Text] [Related]
2. Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation.
Wex J; Connolly M; Rath W
BMC Pregnancy Childbirth; 2009 Jun; 9():23. PubMed ID: 19538754
[TBL] [Abstract][Full Text] [Related]
3. [Atosiban treatment for preterm labor--financial considerations and savings by implementing clinical guidelines].
Hadar E; Mansur N; Ambar I; Hod M
Harefuah; 2011 Jun; 150(6):502-6, 553. PubMed ID: 21800486
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of ritodrine and fenoterol for treatment of preterm labor in a low-middle-income country: a case study.
Jakovljevic M; Varjacic M; Jankovic SM
Value Health; 2008; 11(2):149-53. PubMed ID: 18380627
[TBL] [Abstract][Full Text] [Related]
5. Atosiban versus betamimetics in the treatment of preterm labour in Italy: clinical and economic importance of side-effects.
Wex J; Abou-Setta AM; Clerici G; Di Renzo GC
Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):128-35. PubMed ID: 21620558
[TBL] [Abstract][Full Text] [Related]
6. Healthcare evaluation of the use of atosiban and fibronectin for the management of pre-term labour.
Siassakos D; O'Brien K; Draycott T
J Obstet Gynaecol; 2009 Aug; 29(6):507-11. PubMed ID: 19697198
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness and safety of atosiban vs. pulsatile administration of fenoterol in the treatment of preterm labour].
Nonnenmacher A; Hopp H; Dudenhausen J
Z Geburtshilfe Neonatol; 2009 Oct; 213(5):201-6. PubMed ID: 19856243
[TBL] [Abstract][Full Text] [Related]
8. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
European Atosiban Study Group
Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
[TBL] [Abstract][Full Text] [Related]
9. Atosiban versus usual care for the management of preterm labor.
Husslein P; Cabero Roura L; Dudenhausen JW; Helmer H; Frydman R; Rizzo N; Schneider D
J Perinat Med; 2007; 35(4):305-13. PubMed ID: 17614750
[TBL] [Abstract][Full Text] [Related]
10. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
French/Australian Atosiban Investigators Group
Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128
[TBL] [Abstract][Full Text] [Related]
11. [Tocolysis in preterm labour--current recommendations].
Wielgoś M; Bomba-Opoń DA
Ginekol Pol; 2014 May; 85(5):332-4. PubMed ID: 25011212
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women.
Lin CH; Lin SY; Shyu MK; Chen SU; Lee CN
J Formos Med Assoc; 2009 Jun; 108(6):493-501. PubMed ID: 19515630
[TBL] [Abstract][Full Text] [Related]
13. Atosiban and nifedipin for the treatment of preterm labor.
Kashanian M; Akbarian AR; Soltanzadeh M
Int J Gynaecol Obstet; 2005 Oct; 91(1):10-4. PubMed ID: 16043178
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study.
Moutquin JM; Sherman D; Cohen H; Mohide PT; Hochner-Celnikier D; Fejgin M; Liston RM; Dansereau J; Mazor M; Shalev E; Boucher M; Glezerman M; Zimmer EZ; Rabinovici J
Am J Obstet Gynecol; 2000 May; 182(5):1191-9. PubMed ID: 10819857
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
Worldwide Atosiban versus Beta-agonists Study Group
BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
[TBL] [Abstract][Full Text] [Related]
16. Atosiban and nifedipine in the suppression of pre-term labour: a comparative study.
Saleh SS; Al-Ramahi MQ; Al Kazaleh FA
J Obstet Gynaecol; 2013 Jan; 33(1):43-5. PubMed ID: 23259877
[TBL] [Abstract][Full Text] [Related]
17. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
Husslein P; Roura LC; Dudenhausen J; Helmer H; Frydman R; Rizzo N; Schneider D;
BJOG; 2006 Dec; 113 Suppl 3():105-10. PubMed ID: 17206976
[TBL] [Abstract][Full Text] [Related]
18. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.
Valenzuela GJ; Sanchez-Ramos L; Romero R; Silver HM; Koltun WD; Millar L; Hobbins J; Rayburn W; Shangold G; Wang J; Smith J; Creasy GW
Am J Obstet Gynecol; 2000 May; 182(5):1184-90. PubMed ID: 10819856
[TBL] [Abstract][Full Text] [Related]
19. Atosiban.
Shubert PJ
Clin Obstet Gynecol; 1995 Dec; 38(4):722-4. PubMed ID: 8616970
[TBL] [Abstract][Full Text] [Related]
20. Atosiban versus fenoterol as a uterine relaxant for external cephalic version: randomised controlled trial.
Velzel J; Vlemmix F; Opmeer BC; Molkenboer JF; Verhoeven CJ; van Pampus MG; Papatsonis DN; Bais JM; Vollebregt KC; van der Esch L; Van der Post JA; Mol BW; Kok M
BMJ; 2017 Jan; 356():i6773. PubMed ID: 28126898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
